REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 202 filers reported holding REATA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,611 | -4.0% | 25,604 | -14.4% | 1.81% | -5.0% |
| Q1 2023 | $2,719 | +135.8% | 29,907 | -1.5% | 1.91% | +121.6% |
| Q4 2022 | $1,153 | -99.8% | 30,359 | 0.0% | 0.86% | +39.8% |
| Q3 2022 | $763,000 | -17.3% | 30,359 | 0.0% | 0.62% | -10.9% |
| Q2 2022 | $923,000 | -7.6% | 30,359 | 0.0% | 0.69% | +8.0% |
| Q1 2022 | $999,000 | +24.7% | 30,359 | 0.0% | 0.64% | +37.3% |
| Q4 2021 | $801,000 | -73.8% | 30,359 | 0.0% | 0.47% | -74.4% |
| Q3 2021 | $3,054,000 | -28.9% | 30,359 | 0.0% | 1.82% | -28.7% |
| Q2 2021 | $4,297,000 | +42.0% | 30,359 | -0.0% | 2.55% | +34.0% |
| Q1 2021 | $3,027,000 | -19.4% | 30,368 | 0.0% | 1.91% | -22.0% |
| Q4 2020 | $3,754,000 | +26.9% | 30,368 | 0.0% | 2.44% | +9.2% |
| Q3 2020 | $2,958,000 | -37.6% | 30,368 | 0.0% | 2.24% | -41.1% |
| Q2 2020 | $4,738,000 | +8.1% | 30,368 | 0.0% | 3.80% | -10.3% |
| Q1 2020 | $4,383,000 | -53.6% | 30,368 | -31.1% | 4.24% | -35.1% |
| Q4 2019 | $9,451,000 | +167.0% | 44,096 | 0.0% | 6.54% | +145.6% |
| Q3 2019 | $3,540,000 | -4.6% | 44,096 | 0.0% | 2.66% | -2.9% |
| Q2 2019 | $3,710,000 | -18.7% | 44,096 | -17.4% | 2.74% | +6.8% |
| Q1 2019 | $4,564,000 | +52.3% | 53,404 | 0.0% | 2.57% | -2.3% |
| Q4 2018 | $2,996,000 | -39.7% | 53,404 | -12.1% | 2.63% | -31.0% |
| Q3 2018 | $4,969,000 | +57.5% | 60,775 | -32.6% | 3.81% | +50.1% |
| Q2 2018 | $3,154,000 | +70.5% | 90,200 | 0.0% | 2.54% | +65.6% |
| Q1 2018 | $1,850,000 | -17.9% | 90,200 | 0.0% | 1.53% | -17.4% |
| Q4 2017 | $2,254,000 | -19.6% | 90,200 | 0.0% | 1.85% | -22.4% |
| Q3 2017 | $2,805,000 | -1.7% | 90,200 | 0.0% | 2.39% | -7.3% |
| Q2 2017 | $2,854,000 | +39.7% | 90,200 | 0.0% | 2.58% | +33.0% |
| Q1 2017 | $2,043,000 | +3.8% | 90,200 | 0.0% | 1.94% | -1.3% |
| Q4 2016 | $1,969,000 | – | 90,200 | – | 1.96% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |